Financial Services · Financial Data & Stock Exchanges
Made onAug 16, 2026
Price at call$97.02
6-month call Bear -7.8%
Target by Feb 2027$89.50
Great value below$78.00
Modelv0.6.0
Projection vs Actual
(6M history + forecast)
The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change-7.8% to $89.50
Predicted High$98.50at 2 months
Predicted Low$89.50at 6 months
Max Drawdown (predicted)-7.8%
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Aug 16, 2026 12:40 am
Bear
NDAQ trends lower to
$89.50
(-7.8% from $97.02)
by Feb 2027.
decay
ThesisNDAQ trades well above every intrinsic anchor but sits in a risk-on tape with low beta, durable platform narrative, and consistent earnings beats. Expect a mild drift lower as value gravity slowly reasserts, with an October earnings print offering a possible bounce before resumed fade.
Invalidated ifA close above $105 on strong Q3 print, or a break below $88 on regime flip to risk-off, would invalidate.
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $97.02 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Aug 16, 2026
—
$97.02at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Aug 30, 2026
$90.70–$103.34typical range · internal point $97.30
—
±6.5%
6/10
Risk-on tape and low beta keep drift minimal
1 month
Sep 16, 2026
$87.87–$106.17typical range · internal point $96.20
—
±9.4%
5/10
Momentum cooling as valuation stretch persists
2 months
Oct 16, 2026
$98.50
—
+1.5%
4/10
Q3 earnings beat likely lifts shares briefly
3 months
Nov 16, 2026
$95.40
—
-1.7%
5/10
Post-print fade as value gravity reasserts
4 months
Dec 16, 2026
$93.00
—
-4.1%
5/10
Year-end derisking trims premium multiples
5 months
Jan 16, 2027
$91.20
—
-6.0%
4/10
January repositioning away from expensive defensives
6 months
Feb 16, 2027
$89.50
—
-7.8%
4/10
Slow convergence toward anchored-PE fair value
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$92.47
(-4.7%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.